BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6025735)

  • 1. Cytogenetic studies in multiple myeloma: a study of fourteen cases.
    Tassoni EM; Durant JR; Becker S; Kravitz B
    Cancer Res; 1967 Apr; 27(4):806-10. PubMed ID: 6025735
    [No Abstract]   [Full Text] [Related]  

  • 2. Conventional cytogenetics in myeloma.
    Campbell LJ
    Methods Mol Med; 2005; 113():37-47. PubMed ID: 15968093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
    Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
    Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symposium. Myeloma. e. Chromosome abnormality and its significance in human multiple myeloma.
    Itani S; Hoshino T; Kawasaki S; Nakayama S
    Nihon Ketsueki Gakkai Zasshi; 1970 Feb; 33(1):54-66. PubMed ID: 5530150
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations.
    Calasanz MJ; Cigudosa JC; Odero MD; Ferreira C; Ardanaz MT; Fraile A; Carrasco JL; Solé F; Cuesta B; Gullón A
    Genes Chromosomes Cancer; 1997 Feb; 18(2):84-93. PubMed ID: 9115968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G-banding of 3 multiple myeloma marker chromosomes.
    Philip P; Drivsholm AA
    Biomedicine; 1974 Nov; 21(11):429-30. PubMed ID: 4142930
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cytogenetical and clinico-hematological changes in myeloma disease].
    Dubrova SE; Dygin VP; Ushakova EA
    Tsitologiia; 1966; 8(2):241-9. PubMed ID: 5984072
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chromosome abnormalities during chronic lymphoid leukemia, malignant lymphoreticular process and Kahler's disease].
    Broustet A; Meuge C; Legrand E
    Nouv Rev Fr Hematol; 1970; 10(1):91-9. PubMed ID: 4246339
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of the study of the activity of bone marrow nucleolar organizers in patients with multiple myeloma].
    Mamaev NN; Mamaeva SE; Ushakova EA; Liburkina IL; Pozniak EI
    Tsitol Genet; 1986; 20(2):91-7. PubMed ID: 2422800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The significance and current diagnostic options of cytogenetic changes in multiple myeloma].
    Kuglík P; Filková H; Oltová A; Hájek R
    Vnitr Lek; 2006 Nov; 52 Suppl 2():76-8. PubMed ID: 18175433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chromosome abnormalities in paraproteinemia].
    Siebner H; Spengler GA; Bütler R; Heni F; Riva G
    Schweiz Med Wochenschr; 1965 Dec; 95(52):1767-77. PubMed ID: 4959233
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicolor spectral karyotyping in multiple myeloma.
    Sawyer JR
    Methods Mol Med; 2005; 113():49-58. PubMed ID: 15968094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A modified cytogenetic study for multiple myeloma].
    Qin YW; Wei DL; Wang C; Yan SK; Gao YR; Cai Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):213-5. PubMed ID: 16604501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chromosome studies in paraproteinemia].
    Kanzow U; Lange B; Niederalt G; Gropp A
    Klin Wochenschr; 1967 Nov; 45(21):1076-84. PubMed ID: 4970245
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytogenetics of malignant hemopathies: update].
    Lai JL; Genevière F; Zandecki M
    Bull Cancer; 1999 Jan; 86(1):23-8. PubMed ID: 10029700
    [No Abstract]   [Full Text] [Related]  

  • 17. [Characteristics of chromosomal complexes in patients with narrow-band (monoclonal) gammapathies (literature survey)].
    Zakharova AV
    Probl Gematol Pereliv Krovi; 1975 Feb; 20(2):53-62. PubMed ID: 810791
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytogenetic sequelae of whole-body and local irradiation in bone marrow cells of mice].
    Bikkulov RI; Grechishkin SV
    Vestn Akad Med Nauk SSSR; 1968; 23(12):80-3. PubMed ID: 5744509
    [No Abstract]   [Full Text] [Related]  

  • 19. Chromosome aberrations in a series of 120 multiple myeloma cases with abnormal karyotypes.
    Mohamed AN; Bentley G; Bonnett ML; Zonder J; Al-Katib A
    Am J Hematol; 2007 Dec; 82(12):1080-7. PubMed ID: 17654686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chromosome anomalies in Venezuelan patients with multiple myeloma].
    Quintero M; Rojas-Atencio A; Ruiz A; González M; Herrera J; Atencio F; Delgado W; Urdaneta K; Pérez F
    Invest Clin; 2003 Dec; 44(4):327-35. PubMed ID: 14727386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.